iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
In a 2011 report, Princeton researchers described making six alkaloids—including strychnine—from one common synthetic precursor. The strategy, called collective total synthesis, uses a versatile intermediate and different catalyst-directed reaction cascades to branch toward multiple products. “Parent molecule” here means that shared precursor, not a biological ancestor or one universal route.
What the 2011 synthesis achieved
The team built a tetracyclic spiroindoline precursor containing several reactive sites, which the researchers described as “redundant functionalities.” Different catalysts could engage those sites and direct sequences of reactions toward different alkaloids. Instead of designing six entirely separate routes from the outset, the chemists made a common core that could be steered into several end products.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Organic Chemistry | $125.24 | Buy on Amazon |
| 2 |
|
Organic Chemistry (MasteringChemistry) | $319.99 | Buy on Amazon |
| 3 |
|
Organic Chemistry as a Second Language: First Semester Topics | $76.48 | Buy on Amazon |
| 4 |
|
Organic Chemistry | $65.32 | Buy on Amazon |
| 5 |
|
Organic Chemistry I For Dummies (For Dummies (Math & Science)) | $11.48 | Buy on Amazon |
Chemistry World reported that the six products required 36 steps in total—an average of six steps per product. The researchers compared this with about 12 steps per molecule in the best systems in the literature at that time. That is a historical comparison reported in 2011, not a current, like-for-like benchmark for natural-product synthesis generally. The report cites the underlying paper by S. B. Jones and colleagues, DOI 10.1038/nature10232.
Why one precursor can yield several products
A conventional total synthesis is planned around reaching a particular target molecule. In a collective approach, chemists instead prepare an intermediate with multiple useful reaction sites. Choosing different catalysts can then initiate different transformations and cascades, changing how that shared structure is elaborated into a final product.
#1 Best Overall
The advantage is strategic: a common intermediate can serve as a branching point, so its preparation contributes to more than one target. It does not mean every product follows an identical route after that point, or that a single intermediate can produce any natural product. The chemistry depends on the intermediate’s structure and on catalysts and reaction sequences that selectively direct the desired transformations.
How later enzyme-guided scaffold editing differs
A later chemoenzymatic method also starts from a shared molecular scaffold, but it is a distinct strategy from the 2011 collective total synthesis. Rather than branching from the tetracyclic spiroindoline precursor to complete different natural products, it modifies existing natural-product scaffolds through enzyme-guided oxidation followed by chemical skeletal edits.
Rank #2
In the later study, engineered cytochrome P450 enzymes hydroxylated selected aliphatic C–H positions, including remote positions on some substrates. Subsequent oxidation to ketones enabled chemical ring expansion through Baeyer–Villiger rearrangement or ketone homologation. Different enzyme variants could direct oxidation to different sites. Across the studied substrates, the researchers reported 17 skeletally edited derivatives.
Recommended Free Tools
The scope was not universal: epoxidation competed with ring expansion for some substrates; 2-oxo-micheliolide did not undergo the desired expansion under the tested conditions; and a totarol-derived phenol decomposed during rearrangement conditions. These outcomes show why enzyme selectivity and substrate compatibility matter to this approach. The reported study is available at Nature.
What the biological results do—and do not—show
The skeletal-editing study tested compounds in cell lines, not in clinical trials. Most edited compounds showed no detectable anticancer activity in the study’s panel. Two analogues showed selective activity in the tested cell lines: parthenolide derivative 20 had an ED50 of 21 ± 3 μM against H1155 cells, and artemisinin derivative 30 had an ED50 of 25 ± 4 μM against H1155 cells. These are assay-specific findings and do not establish efficacy in people.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.A separate parthenolide-based diversity study
Another chemoenzymatic diversity-oriented synthesis study began with parthenolide and reported generating a collection of about 50 complex natural-product-like molecules. It combined P450-catalyzed oxyfunctionalization with divergent chemical steps. This is separate from both the six-alkaloid synthesis reported in 2011 and the later skeletal-editing study; the shared theme is using enzyme-enabled chemistry to diversify a scaffold, not a single common experiment. See the paper at Nature.
Quick Recap
Best Value
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Scan for outdated or missing drivers - takes under a minute3Repair Windows errors before they cause bigger problems
